US Patent Issued to Chia Tai Tianqing Pharmaceutical Group on Aug. 5 for "Quinoline derivative used for soft tissue sarcoma combination therapy" (Chinese Inventors)

ALEXANDRIA, Va., Aug. 6 -- United States Patent no. 12,377,089, issued on Aug. 5, was assigned to Chia Tai Tianqing Pharmaceutical Group Co. Ltd. (Lianyungang, China).

"Quinoline derivative used for soft tissue sarcoma combination therapy" was invented by Zhiming Wang (Shanghai), Shilong Zhang (Shanghai), Rongyuan Zhuang (Shanghai), Xi Guo (Shanghai), Yan Wang (Shanghai), Hua Yang (Shanghai), Weiqi Lu (Shanghai), Yuhong Zhou (Shanghai) and Lei Gao (Lianyungang, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "A quinoline derivative used for soft tissue sarcoma combination therapy, relating to a use of the quinoline derivative in combination with a second therapeutic drug to treat soft tissue sarcoma, whe...